{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:03:46Z","timestamp":1760976226543,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10815-022-02430-2","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T02:02:20Z","timestamp":1644544940000},"page":"747-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A cross-sectional survey of genetic counselors providing carrier screening regarding\u00a0GBA\u00a0variants and Parkinson disease susceptibility"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1865-9538","authenticated-orcid":false,"given":"Tara A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4424-8588","authenticated-orcid":false,"given":"Sharon","family":"Aufox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7863-2388","authenticated-orcid":false,"given":"Aishwarya","family":"Arjunan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"issue":"3","key":"2430_CR1","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/AOG.0000000000001952","volume":"129","author":"Committee Opinion No. 691","year":"2017","unstructured":"Committee Opinion No. 691. Carrier screening for genetic conditions. Obstet Gynecol. 2017;129(3):e41\u201355. https:\/\/doi.org\/10.1097\/AOG.0000000000001952.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2430_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10897-012-9524-8","volume":"21","author":"B Finucane","year":"2012","unstructured":"Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A. Genetic counseling and testing for FMR1 gene mutations: practice guidelines of the national society of genetic counselors. J Genet Couns. 2012;21(6):752\u201360. https:\/\/doi.org\/10.1007\/s10897-012-9524-8.","journal-title":"J Genet Couns"},{"issue":"9","key":"2430_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fpsyt.2018.00564","volume":"13","author":"RJ Hagerman","year":"2018","unstructured":"Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-associated neuropsychiatric disorders (FXAND). Front Psychiatry. 2018;13(9):564. https:\/\/doi.org\/10.3389\/fpsyt.2018.00564.","journal-title":"Front Psychiatry"},{"issue":"19","key":"2430_CR4","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1158\/0008-5472.CAN-07-1501","volume":"67","author":"M Berwick","year":"2007","unstructured":"Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res. 2007;67(19):9591\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1501.","journal-title":"Cancer Res"},{"issue":"4","key":"2430_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ijc.23168","volume":"122","author":"N Bogdanova","year":"2008","unstructured":"Bogdanova N, Feshchenko S, Sch\u00fcrmann P, Waltes R, Wieland B, Hillemanns P, Rogov YI, Dammann O, Bremer M, Karstens JH, Sohn C, Varon R, D\u00f6rk T. Nijmegen breakage syndrome mutations and risk of breast cancer. Int J Cancer. 2008;122(4):802\u20136. https:\/\/doi.org\/10.1002\/ijc.23168.","journal-title":"Int J Cancer"},{"issue":"5","key":"2430_CR6","doi-asserted-by":"publisher","first-page":"14060","DOI":"10.1038\/srep14060","volume":"11","author":"RM de Voer","year":"2015","unstructured":"de Voer RM, Hahn MM, Mensenkamp AR, Hoischen A, Gilissen C, Henkes A, Spruijt L, van Zelst-Stams WA, Kets CM, Verwiel ET, Nagtegaal ID, Schackert HK, van Kessel AG, Hoogerbrugge N, Ligtenberg MJ, Kuiper RP. Deleterious germline BLM mutations and the risk for early-onset colorectal cancer. Sci Rep. 2015;11(5):14060. https:\/\/doi.org\/10.1038\/srep14060.","journal-title":"Sci Rep"},{"issue":"2","key":"2430_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ijc.1329","volume":"93","author":"B Geoffroy-Perez","year":"2001","unstructured":"Geoffroy-Perez B, Janin N, Ossian K, Laug\u00e9 A, Croquette MF, Griscelli C, Debr\u00e9 M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer. 2001;93(2):288\u201393. https:\/\/doi.org\/10.1002\/ijc.1329.","journal-title":"Int J Cancer"},{"issue":"5","key":"2430_CR8","first-page":"347","volume":"8","author":"R Kannai","year":"2006","unstructured":"Kannai R, Chertok IR. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population. Isr Med Assoc J. 2006;8(5):347\u201350.","journal-title":"Isr Med Assoc J"},{"issue":"10","key":"2430_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/gim.2012.63","volume":"14","author":"D Falcone","year":"2012","unstructured":"Falcone D, Wood EM, Mennuti M, Xie SX, Van Deerlin VM. Prenatal healthcare providers\u2019 Gaucher disease carrier screening practices. Genet Med. 2012;14(10):844\u201351. https:\/\/doi.org\/10.1038\/gim.2012.63.","journal-title":"Genet Med"},{"issue":"12","key":"2430_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/jmg.2004.024455","volume":"41","author":"O Goker-Alpan","year":"2004","unstructured":"Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Parkinsonism among Gaucher disease carriers. J Med Genet. 2004;41(12):937\u201340. https:\/\/doi.org\/10.1136\/jmg.2004.024455.","journal-title":"J Med Genet"},{"issue":"2","key":"2430_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/gim.2012.107","volume":"15","author":"HQ Rana","year":"2013","unstructured":"Rana HQ, Balwani M, Bier L, Alcalay RN. Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling. Genet Med. 2013;15(2):146\u20139. https:\/\/doi.org\/10.1038\/gim.2012.107.","journal-title":"Genet Med"},{"issue":"1","key":"2430_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bcmd.2010.10.006","volume":"46","author":"B Rosenbloom","year":"2011","unstructured":"Rosenbloom B, Balwani M, Bronstein JM, Kolodny E, Sathe S, Gwosdow AR, Taylor JS, Cole JA, Zimran A, Weinreb NJ. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol Dis. 2011;46(1):95\u2013102. https:\/\/doi.org\/10.1016\/j.bcmd.2010.10.006.","journal-title":"Blood Cells Mol Dis"},{"issue":"9","key":"2430_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","volume":"84","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 2015;84(9):880\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000001315.","journal-title":"Neurology"},{"issue":"6","key":"2430_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5(6):525\u201335. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9.","journal-title":"Lancet Neurol"},{"issue":"8","key":"2430_CR15","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm (Vienna). 2017;124(8):901\u20135. https:\/\/doi.org\/10.1007\/s00702-017-1686-y.","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"2430_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2217\/bmm.10.96","volume":"4","author":"G Lopez","year":"2010","unstructured":"Lopez G, Sidransky E. Autosomal recessive mutations in the development of Parkinson\u2019s disease. Biomark Med. 2010;4(5):713\u201321. https:\/\/doi.org\/10.2217\/bmm.10.96.","journal-title":"Biomark Med"},{"issue":"1","key":"2430_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.semperi.2015.11.005","volume":"40","author":"GA Lazarin","year":"2016","unstructured":"Lazarin GA, Haque IS. Expanded carrier screening: a review of early implementation and literature. Semin Perinatol. 2016;40(1):29\u201334. https:\/\/doi.org\/10.1053\/j.semperi.2015.11.005.","journal-title":"Semin Perinatol"},{"issue":"6","key":"2430_CR18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/gim.2013.47","volume":"15","author":"WW Grody","year":"2013","unstructured":"Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, Lebo RV. ACMG position statement on prenatal\/preconception expanded carrier screening. Genet Med. 2013;15(6):482\u20133. https:\/\/doi.org\/10.1038\/gim.2013.47.","journal-title":"Genet Med"},{"key":"2430_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01203-z","author":"AR Gregg","year":"2021","unstructured":"Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, Chen E, Sparks TN, Reddi HV, Rajkovic A, Dungan JS, ACMG Professional Practice and Guidelines Committee. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021. https:\/\/doi.org\/10.1038\/s41436-021-01203-z.","journal-title":"Genet Med"},{"issue":"1","key":"2430_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10897-015-9854-4","volume":"25","author":"A Reeves","year":"2016","unstructured":"Reeves A, Trepanier A. Comparison of informed consent preferences for multiplex genetic carrier screening among a diverse population. J Genet Couns. 2016;25(1):166\u201378. https:\/\/doi.org\/10.1007\/s10897-015-9854-4.","journal-title":"J Genet Couns"},{"issue":"4","key":"2430_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10897-007-9094-3","volume":"16","author":"KE Ormond","year":"2007","unstructured":"Ormond KE, Iris M, Banuvar S, Minogue J, Annas GJ, Elias S. What do patients prefer: informed consent models for genetic carrier testing. J Genet Couns. 2007;16(4):539\u201350. https:\/\/doi.org\/10.1007\/s10897-007-9094-3.","journal-title":"J Genet Couns"},{"issue":"2","key":"2430_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pec.2008.09.020","volume":"75","author":"KE Ormond","year":"2009","unstructured":"Ormond KE, Banuvar S, Daly A, Iris M, Minogue J, Elias S. Information preferences of high literacy pregnant women regarding informed consent models for genetic carrier screening. Patient Educ Couns. 2009;75(2):244\u201350. https:\/\/doi.org\/10.1016\/j.pec.2008.09.020.","journal-title":"Patient Educ Couns"},{"issue":"8","key":"2430_CR23","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/risa.12161","volume":"34","author":"PM Allen","year":"2014","unstructured":"Allen PM, Edwards JA, Snyder FJ, Makinson KA, Hamby DM. The effect of cognitive load on decision making with graphically displayed uncertainty information. Risk Anal. 2014;34(8):1495\u2013505. https:\/\/doi.org\/10.1111\/risa.12161.","journal-title":"Risk Anal"},{"issue":"2","key":"2430_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzales N, et al. Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"9","key":"2430_CR25","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/ajmg.a.34155","volume":"155A","author":"S Lieberman","year":"2011","unstructured":"Lieberman S, Zuckerman S, Levy-Lahad E, Altarescu G. Conflicts regarding genetic counseling for fragile X syndrome screening: a survey of clinical geneticists and genetic counselors in Israel. Am J Med Genet A. 2011;155A(9):2154\u201360. https:\/\/doi.org\/10.1002\/ajmg.a.34155.","journal-title":"Am J Med Genet A"},{"key":"2430_CR26","unstructured":"National Society of Genetic Counselors (NSGC), Inc. (2017). NSGC Code of Ethics. Accessed August 29, 2020, from https:\/\/www.nsgc.org\/p\/cm\/ld\/fid=12"},{"key":"2430_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12687-0168-7","volume":"5","author":"TM Scuffham","year":"2014","unstructured":"Scuffham TM, McInerny-Leo A, Ng SK, Mellick G. Knowledge and attitudes towards genetic testing in those affected with Parkinson\u2019s disease. J Community Genet. 2014;5:167\u201377. https:\/\/doi.org\/10.1007\/s12687-0168-7.","journal-title":"J Community Genet"},{"key":"2430_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jgc4.1185","volume":"29","author":"L Zaretsky","year":"2019","unstructured":"Zaretsky L, Zeid N, Naik H, Alcalay RN, Balwani M. Knowledge and attitudes of Parkinson\u2019s disease risk in the Gaucher population. J Genet Couns. 2019;29:105\u201311. https:\/\/doi.org\/10.1002\/jgc4.1185.","journal-title":"J Genet Couns"},{"key":"2430_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10897-017-0161-0","author":"M Mulhern","year":"2017","unstructured":"Mulhern M, Bier L, Alcalay RN, Balwani M. Patients\u2019 opinions on genetic counsel ing on the increased risk of Parkinson disease among Gaucher disease carriers. J Genet Counsel. 2017. https:\/\/doi.org\/10.1007\/s10897-017-0161-0.","journal-title":"J Genet Counsel"},{"issue":"9","key":"2430_CR30","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/pd.5995","volume":"41","author":"L Rabkina","year":"2021","unstructured":"Rabkina L, Swanson A, Aufox S, Propst L, Fiddler M, Wagner A, Arjunan A. What women want: general population perspectives and access to preconception expanded carrier screening. Prenat Diagn. 2021;41(9):1057\u201365. https:\/\/doi.org\/10.1002\/pd.5995.","journal-title":"Prenat Diagn"},{"issue":"10","key":"2430_CR31","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1007\/s10815-021-02270-6","volume":"38","author":"J Choi","year":"2021","unstructured":"Choi J, Kane T, Propst L, Spencer S, Kostialik J, Arjunan A. Not just carriers: experiences of X-linked female heterozygotes. J Assist Reprod Genet. 2021;38(10):2757\u201367. https:\/\/doi.org\/10.1007\/s10815-021-02270-6.","journal-title":"J Assist Reprod Genet"},{"key":"2430_CR32","unstructured":"National Society of Genetic Counselors. 2021 Professional status survey: executive summary. 2021. Accessed January 8, 2022.https:\/\/www.nsgc.org\/Portals\/0\/Executive%20Summary%202021%20FINAL%2005-03-21.pdf"},{"issue":"12","key":"2430_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.nmd.2016.09.008","volume":"26","author":"Lauren Bogue","year":"2016","unstructured":"Lauren, Bogue Holly, Peay Ann, Martin Ann, Lucas Sindhu, Ramchandren (2016) Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy. Neuromuscular Disorders 26(12) 860-864 10.1016\/j.nmd.2016.09.008","journal-title":"Neuromuscular Disorders"},{"key":"2430_CR34","doi-asserted-by":"crossref","unstructured":"Marc, Engelen Mathieu, Barbier Inge M. E., Dijkstra Remmelt, Sch\u00fcr Rob M. A., de Bie Camiel, Verhamme Marcel G. W., Dijkgraaf Patrick A., Aubourg Ronald J. A., Wanders Bjorn M., van Geel Marianne, de Visser Bwee T., Poll\u2013The Stephan, Kemp (2014) (2014) (2014) X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain 137(3) 693-706 10.1093\/brain\/awt361","DOI":"10.1093\/brain\/awt361"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02430-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02430-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T02:06:44Z","timestamp":1649642804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02430-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2430"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02430-2","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"type":"print","value":"1058-0468"},{"type":"electronic","value":"1573-7330"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"assertion":[{"value":"16 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AA was an\u00a0employee and shareholder of Myriad Genetics, a laboratory that offers carrier screening at the time of study. TJ holds shares in Invitae and Myriad, both genetic laboratories offering carrier screening. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}